| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-156 |
Sentence |
denotes |
Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His. |
| T1 |
0-156 |
Sentence |
denotes |
Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His. |
| TextSentencer_T2 |
157-368 |
Sentence |
denotes |
LEOPARD syndrome (LS), generally caused by heterozygous mutations in the PTPN11 gene, is a rare autosomal-dominant multiple congenital anomaly condition, characterized by skin, facial, and cardiac abnormalities. |
| T2 |
157-368 |
Sentence |
denotes |
LEOPARD syndrome (LS), generally caused by heterozygous mutations in the PTPN11 gene, is a rare autosomal-dominant multiple congenital anomaly condition, characterized by skin, facial, and cardiac abnormalities. |
| TextSentencer_T3 |
369-521 |
Sentence |
denotes |
Prognosis appears to be related to the type of structural, myocardial, and arrhythmogenic cardiac disease, especially hypertrophic cardiomyopathy (HCM). |
| T3 |
369-521 |
Sentence |
denotes |
Prognosis appears to be related to the type of structural, myocardial, and arrhythmogenic cardiac disease, especially hypertrophic cardiomyopathy (HCM). |
| TextSentencer_T4 |
522-760 |
Sentence |
denotes |
We report on a woman with LS and a novel Gln510His mutation in PTPN11, who had progressive HCM with congestive heart failure and nonsustained ventricular tachycardia, successfully treated with implantable cardioverter defibrillator (ICD). |
| T4 |
522-760 |
Sentence |
denotes |
We report on a woman with LS and a novel Gln510His mutation in PTPN11, who had progressive HCM with congestive heart failure and nonsustained ventricular tachycardia, successfully treated with implantable cardioverter defibrillator (ICD). |
| TextSentencer_T5 |
761-950 |
Sentence |
denotes |
Comparing our patient to the literature suggests that specific mutations at codon 510 in PTPN11 (Gln510Glu, Gln510His, but not Gln510Pro) might be a predictor of fatal cardiac events in LS. |
| T5 |
761-950 |
Sentence |
denotes |
Comparing our patient to the literature suggests that specific mutations at codon 510 in PTPN11 (Gln510Glu, Gln510His, but not Gln510Pro) might be a predictor of fatal cardiac events in LS. |
| TextSentencer_T6 |
951-1108 |
Sentence |
denotes |
Molecular risk stratification and careful evaluations for an indication of ICD implantation are likely to be beneficial in managing patients with LS and HCM. |
| T6 |
951-1108 |
Sentence |
denotes |
Molecular risk stratification and careful evaluations for an indication of ICD implantation are likely to be beneficial in managing patients with LS and HCM. |